论文部分内容阅读
目的:探讨前列腺增生(CP)与慢性前列腺炎(BPH)的临床关系。方法:对我院泌尿外科收治的前列腺增生病例100例患者进行常规前列腺液(EPS)涂片和细菌培养,然后依据EPS培养结果选择敏感抗生素治疗,观察其临床疗效和前列腺炎的并发率。结果:100例患者中伴有CP者89例(89%)。其中Ⅰ度前列腺增生24例,合并CP29例(76.13%);Ⅱ度44例,合并CP32例(84.1%);Ⅲ度27例,合并CP24例(87.4%)。使用敏感抗生素治疗4周后,三组患者IPSS改善率分别为:31.7%,32.2%,15.4%结论:前列腺增生和前列腺炎临床症状有许多相似处,且两者并发率较高,应及时进行EPS等专项检查,加强对前列腺增生并发前列腺炎的诊断治疗。
Objective: To investigate the clinical relationship between benign prostatic hyperplasia (CP) and chronic prostatitis (BPH). Methods: A total of 100 patients with benign prostatic hyperplasia (BPH) admitted to Department of Urology in our hospital underwent conventional prostatic fluid (EPS) smear and bacterial culture. The patients were then treated with sensitive antibiotics according to EPS culture results. The clinical efficacy and incidence of prostatitis were observed. Results: 89 patients (89%) were accompanied by CP in 100 patients. There were 24 cases with degree Ⅰ benign prostatic hyperplasia and 29 cases with CP (76.13%). There were 44 cases with degree Ⅱ, 32 cases with CP (84.1%), 27 cases with Ⅲ degree and 24 cases (87.4%) with CP. After 4 weeks of treatment with sensitive antibiotics, the IPSS improvement rates of the three groups were respectively 31.7%, 32.2% and 15.4% Conclusion: There are many similarities between the clinical symptoms of benign prostatic hyperplasia and prostatitis, and the concurrent rates of the two should be promptly EPS and other special inspection, strengthen the diagnosis and treatment of benign prostatic hyperplasia complicated by prostatitis.